CN Patent

CN110711174A — 一种泊沙康唑注射液中间体溶液配制方法

Assigned to Zhengzhou Taifeng Pharmaceutical Co Ltd · Expires 2020-01-21 · 6y expired

What this patent protects

本发明提供一种能显著缩短泊沙康唑注射液中间体溶液配制时间的制备方法。该方法首先将药物与辅料混合，然后使用溶剂溶解。制备工艺简单，可操作性强，制备工艺温和，药物不发生降解等。该工艺在保证产品质量的前提下，显著缩短工艺时间，降低生产成本。

USPTO Abstract

本发明提供一种能显著缩短泊沙康唑注射液中间体溶液配制时间的制备方法。该方法首先将药物与辅料混合，然后使用溶剂溶解。制备工艺简单，可操作性强，制备工艺温和，药物不发生降解等。该工艺在保证产品质量的前提下，显著缩短工艺时间，降低生产成本。

Drugs covered by this patent

Patent Metadata

Patent number
CN110711174A
Jurisdiction
CN
Classification
—
Expires
2020-01-21
Drug substance claim
No
Drug product claim
No
Assignee
Zhengzhou Taifeng Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.